Patents by Inventor Andrew John Holyoake

Andrew John Holyoake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of recurrent gastric cancer identified using genetic biomarkers
    Patent number: 10689707
    Abstract: Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the GTM gene family can be over-expressed in gastric tumor tissue and other tumor tissue, and thus can be used as markers for gastric and other types of cancer. GTM proteins can be released from cancer cells, and can reach sufficiently high concentrations in the serum and/or other fluids to permit their detection. Thus, methods and test kits for detection and quantification of GTM can provide a valuable tool for diagnosis of gastric cancer.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: June 23, 2020
    Assignee: Pacific Edge Limited
    Inventors: Parry John Guilford, Andrew John Holyoake
  • Markers for detection of gastric cancer
    Patent number: 10179935
    Abstract: Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the GTM gene family can be over-expressed in gastric tumor tissue and other tumor tissue, and thus can be used as markers for gastric and other types of cancer. GTM proteins can be released from cancer cells, and can reach sufficiently high concentrations in the serum and/or other fluids to permit their detection. Thus, methods and test kits for detection and quantification of GTM can provide a valuable tool for diagnosis of gastric cancer.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: January 15, 2019
    Assignee: PACIFIC EDGE LIMITED
    Inventors: Parry John Guilford, Andrew John Holyoake
  • PCR-Based Assays for Nucleic Acids
    Publication number: 20160369355
    Abstract: Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the GTM gene family can be over-expressed in gastric tumor tissue and other tumor tissue, and thus can be used as markers for gastric and other types of cancer. GTM proteins can be released from cancer cells, and can reach sufficiently high concentrations in the serum and/or other fluids to permit their detection. Thus, methods and test kits for detection and quantification of GTM can provide a valuable tool for diagnosis of gastric cancer.
    Type: Application
    Filed: August 31, 2016
    Publication date: December 22, 2016
    Applicant: Pacific Edge Limited
    Inventors: Parry John Guilford, Andrew John Holyoake